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The healthcare profession is exceptionally innovative, 
yet many groundbreaking ideas for whatever reason fail
toleave the drawing board. Medical Futures is dedicated
to encouraging and promoting a culture of creativity
andinnovation amongst healthcare professionals 
and facilitating the successful commercialisation 
of their ideas.
The Medical Futures Innovation Awards create a plat-
form that brings together high-level policy makers,
strategic thinkers and the grassroots practitioners who
deliver care.  Each year the Awards attract over 600
entries from a wide spectrum of sources including the
NHS, academic institutions and private businesses.
Entrants include medical professionals (consultants and
juniors, GPs, 
nurses and professions allied to medicine), scientists and
company executives.  Entries to the Awards can be at
any stage of development, from concept to fully 
implemented practices and businesses.
In addition to the annual Awards Ceremony, Medical
Futures publishes the aspirational Medical Futures 
magazine and runs regular networking events including
the unique Intellectual Property Booster events which
enable medical innovators to gain valuable advice and
mentoring from leading advisors in the fields of 
intellectual property, financing and commercialisation.
The 2003 Awards Ceremony, hosted by the BBC’s Phil
Hammond will take place on 30th October at the Royal
Institute of British Architects (RIBA).  James Burke, 
best selling author and TV presenter will address 
the audience of 350 key opinion leaders with 
an inspiring talk on Innovation.  The audience will 
include Government and cross-party policymakers, 
senior representatives of the healthcare, business and
media professions and the leading healthcare innovators.
On the night the 10 Award winners will be announced as
well as the Overall Winner.  The charitable evening is in
aid of the Genetic Interest Group and Cancer Research
UK.  The Awards are run on a not for profit basis and are
made possible through the generous support of industry,
with blue chip sponsors including, Orange, Nomura,
Johnson & Johnson and Pfizer. 
The prestigious judging panel is comprised of 30 leading
figures in science, healthcare and business. Judges
include Sir Richard Sykes, Professor Sir Ara Darzi,
Professor Carol Black, Sir Nicholas Lyell QC and Sir Chris
Evans OBE.  The 30 finalists presented to the judging
panel as part of the decision process leading up to the
Awards, however, the information on winners, will
remain strictly confidential until the awards ceremony
on the 30th October.
In 2002, the Awards and winners attracted over 300
pieces of high quality mainstream media coverage
including national broadcast television (ITN News and
the BBC), radio (National & Regional), the broadsheet
press (The Times, The Sunday Telegraph, Financial Times)
and popular press (Daily Mail, Daily Mirror). In addition
there was extensive coverage by the medical press.  
Winning a Medical Futures Innovation Award offers
entrants the opportunity of both significant exposure in
the press and recognition amongst key opinion leaders in
the healthcare arena as well as credibility with investors.
The endorsement of the Awards allowed several of the
winners to receive financing and help, despite 
previously being turned down.  The 30 finalists in the
2003 Medical Futures Innovation Awards can be seen by
visiting the website, www.medicalfutures.co.uk.. 
Details of the winners will be announced on the 
30th October 2003.
Details of the 2002 Winners in Brief 
• ‘Automated Tissue Engineering’ , developed by 
Dr Chris Mason, a surgeon from UCL, was the overall
winner and winner of the Best Biotechnology 
Start-Up Innovation. 
• ‘Sweet Talk’, a novel text messaging service for
teenagers with diabetes, developed by Dr Victoria
Franklin, a Specialist Registrar in Paediatrics, from 
the University of Dundee was the winner of two
awards, the Best Innovation in Preventive Medicine
and the Best Innovation in Health Communication.
• ‘Imprint Injector’ a revolutionary, painless blunt 
needle auto-injector developed by Peter Crocker and
Dr Kevin Maynard won the Best Business Proposition
Award and went on to receive £100,000 of fast track
funding from NESTA.
• The Acrobot Company Ltd won the Award for 
Best Surgical Innovation, with its Acrobot(r) 
Hands-On Robotic System for Orthopaedic Surgery,
developed by Brian Davies, Professor of Medical
Robotics at Imperial College, London, and his team, 
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in collaboration with Justin Cobb, an NHS
Orthopaedic Surgeon at the Middlesex Hospital.
• A Portable Personal Heart Attack Detector,
developed by Consultant Physician, 
Dr Michael Vassallo of the Royal Bournemouth
Hospital, won the Best Innovation to Improve 
Patient Care Award. 
• ‘Telemedicine Biosensor Smartcard,’ a unique 
invention for capturing and transferring clinical data,
developed by James Jackson, won the Best Innovation
in Integrated Medicine. 
• Recombinant Protein (Surfactant D), a medical
advance in the treatment of babies suffering from
premature lung disease, developed by 
Dr Howard Clark and his team at Oxford University
won the Best Innovation to Improve Child Health. 
• ‘Venox’, a novel non-invasive device to assess 
critically ill patients in the intensive care setting,
developed by  Tomasz Spyt, a Cardiac Surgeon at the
Glenfield Hospital, together with his team at
Loughborough University won the Best 
Medical Innovation.
• ‘Voxar Colonscreen,’ a PC-based “virtual colonoscopy”
solution to detect colorectal cancer less invasively
without the need for sedation developed by Voxar
based in Edinburgh won the Best Diagnostic Imaging
Innovation.
